Since NF-κB regulates cytokine gene expression, inhibiting proliferation and inflammatory responses of keratinocytes through the inactivation of the NF-κB signaling pathway may represent a novel psoriasis treatment (20-22). The gene discussed is NFKB1; the disease is psoriasis.